State Street’s Arena Pharmaceuticals Inc ARNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-2,293,409
| Closed | -$213M | – | 4951 |
|
|
2021
Q4 | $213M | Buy |
2,293,409
+191,409
| +9% | +$12.6M | 0.01% | 833 |
|
|
2021
Q3 | $125M | Buy |
2,102,000
+232,038
| +12% | +$13.7M | 0.01% | 1093 |
|
|
2021
Q2 | $128M | Buy |
1,869,962
+121,170
| +7% | +$7.9M | 0.01% | 1118 |
|
|
2021
Q1 | $121M | Sell |
1,748,792
-321,831
| -16% | -$24.8M | 0.01% | 1090 |
|
|
2020
Q4 | $159M | Buy |
2,070,623
+134,699
| +7% | +$10.1M | 0.01% | 850 |
|
|
2020
Q3 | $145M | Sell |
1,935,924
-139,982
| -7% | -$9.33M | 0.01% | 803 |
|
|
2020
Q2 | $131M | Buy |
2,075,906
+187,295
| +10% | +$10.3M | 0.01% | 818 |
|
|
2020
Q1 | $79.3M | Buy |
1,888,611
+43,910
| +2% | +$2.01M | 0.01% | 969 |
|
|
2019
Q4 | $83.8M | Sell |
1,844,701
-171,398
| -9% | -$8.1M | 0.01% | 1163 |
|
|
2019
Q3 | $92.3M | Buy |
2,016,099
+263,282
| +15% | +$14.8M | 0.01% | 1055 |
|
|
2019
Q2 | $103M | Sell |
1,752,817
-195,947
| -10% | -$10.1M | 0.01% | 1017 |
|
|
2019
Q1 | $87.4M | Sell |
1,948,764
-50,216
| -3% | -$2.3M | 0.01% | 1092 |
|
|
2018
Q4 | $77.9M | Sell |
1,998,980
-390,730
| -16% | -$15.3M | 0.01% | 1056 |
|
|
2018
Q3 | $110M | Buy |
2,389,710
+32,181
| +1% | +$1.3M | 0.01% | 1008 |
|
|
2018
Q2 | $103M | Buy |
2,357,529
+349,659
| +17% | +$15M | 0.01% | 1017 |
|
|
2018
Q1 | $79.3M | Buy |
2,007,870
+587,671
| +41% | +$22.9M | 0.01% | 1130 |
|
|
2017
Q4 | $48.2M | Sell |
1,420,199
-307,619
| -18% | -$8.76M | ﹤0.01% | 1447 |
|
|
2017
Q3 | $44.1M | Buy |
1,727,818
+890,923
| +106% | +$20.4M | ﹤0.01% | 1459 |
|
|
2017
Q2 | $14.1M | Buy |
836,895
+186,716
| +29% | +$2.56M | ﹤0.01% | 2220 |
|
|
2017
Q1 | $9.5M | Buy |
650,179
+27,288
| +4% | +$404K | ﹤0.01% | 2397 |
|
|
2016
Q4 | $8.85M | Buy |
622,891
+35,099
| +6% | +$544K | ﹤0.01% | 2407 |
|
|
2016
Q3 | $10.3M | Buy |
587,792
+28,776
| +5% | +$477K | ﹤0.01% | 2175 |
|
|
2016
Q2 | $9.56M | Sell |
559,016
-139,387
| -20% | -$2.49M | ﹤0.01% | 2247 |
|
|
2016
Q1 | $13.8M | Sell |
698,403
-123,482
| -15% | -$1.98M | ﹤0.01% | 1977 |
|
|
2015
Q4 | $15.6M | Sell |
821,885
-457,713
| -36% | -$9.34M | ﹤0.01% | 1896 |
|
|
2015
Q3 | $24.4M | Buy |
1,279,598
+268,282
| +27% | +$9.11M | ﹤0.01% | 1624 |
|
|
2015
Q2 | $46.9M | Buy |
1,011,316
+176,218
| +21% | +$7.64M | 0.01% | 1313 |
|
|
2015
Q1 | $36.5M | Buy |
835,098
+30,972
| +4% | +$1.44M | ﹤0.01% | 1423 |
|
|
2014
Q4 | $27.9M | Buy |
804,126
+47,751
| +6% | +$1.94M | ﹤0.01% | 1553 |
|
|
2014
Q3 | $31.7M | Buy |
756,375
+92,602
| +14% | +$4.13M | ﹤0.01% | 1418 |
|
|
2014
Q2 | $38.9M | Sell |
663,773
-56,752
| -8% | -$3.57M | ﹤0.01% | 1359 |
|
|
2014
Q1 | $45.4M | Buy |
720,525
+4,098
| +0.6% | +$272K | 0.01% | 1260 |
|
|
2013
Q4 | $41.9M | Sell |
716,427
-73,278
| -9% | -$3.83M | ﹤0.01% | 1300 |
|
|
2013
Q3 | $41.6M | Buy |
789,705
+175,535
| +29% | +$11.8M | 0.01% | 1279 |
|
|
2013
Q2 | $47.3M | Buy |
+614,170
| New | +$50.1M | 0.01% | 1154 |
|
State Street's ARNA Position: Q1 2022 in Review
State Street sold out of Arena Pharmaceuticals Inc (ARNA) in Q1 2022, closing a stake of 2,293,409 shares — an estimated $213M sold.
State Street first reported a position in ARNA in Q2 2013 and held it in 35 quarters. The position peaked at $213M in Q4 2021. 1 fund tracked by Wall St. Rank holds ARNA as of Q1 2022.
- State Street reported no remaining Arena Pharmaceuticals Inc position as of Q1 2022 after selling out during the quarter.
- State Street sold 2,293,409 Arena Pharmaceuticals Inc shares in Q1 2022, an estimated $213M.
- State Street first reported a position in Arena Pharmaceuticals Inc in Q2 2013 and held it in 35 quarters.
- State Street's Arena Pharmaceuticals Inc position peaked at $213M in Q4 2021.
- 1 fund tracked by Wall St. Rank held Arena Pharmaceuticals Inc as of Q1 2022.
Based on State Street's 13F filing for Q1 2022, filed 16 May 2022.